XML 44 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727
Fair Values on Financial Assets and Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Fair value of financial assets and liabilities    
Total financial assets $ 106,474 $ 33,426
Total financial liabilities 3,978 10,485
Money market funds    
Fair value of financial assets and liabilities    
Total financial assets 18,588 [1] 3,912 [2]
Corporate debt securities    
Fair value of financial assets and liabilities    
Total financial assets 13,850 [3] 26,088 [4]
United States government agency securities    
Fair value of financial assets and liabilities    
Total financial assets 62,004 [3] 3,426 [4]
Aduro equity securities    
Fair value of financial assets and liabilities    
Total financial assets [5] 12,032  
Warrant Liability    
Fair value of financial assets and liabilities    
Total financial liabilities 3,978 [6] 10,485 [7]
Level 1    
Fair value of financial assets and liabilities    
Total financial assets 30,620 3,912
Level 1 | Money market funds    
Fair value of financial assets and liabilities    
Total financial assets 18,588 [1] 3,912 [2]
Level 1 | Aduro equity securities    
Fair value of financial assets and liabilities    
Total financial assets [5] 12,032  
Level 2    
Fair value of financial assets and liabilities    
Total financial assets 75,854 29,514
Level 2 | Corporate debt securities    
Fair value of financial assets and liabilities    
Total financial assets 13,850 [3] 26,088 [4]
Level 2 | United States government agency securities    
Fair value of financial assets and liabilities    
Total financial assets 62,004 [3] 3,426 [4]
Level 3    
Fair value of financial assets and liabilities    
Total financial liabilities 3,978 10,485
Level 3 | Warrant Liability    
Fair value of financial assets and liabilities    
Total financial liabilities $ 3,978 [6] $ 10,485 [7]
[1] Included in cash and cash equivalents on the Company's unaudited condensed consolidated balance sheets.
[2] Included in cash and cash equivalents on the Company's consolidated balance sheets.
[3] Included in short-term investments on the Company's unaudited condensed consolidated balance sheets.
[4] Included in short-term investments on the Company's consolidated balance sheets, except for approximately $1.0 million of corporate debt securities that are included in cash and cash equivalents on the Company's consolidated balance sheets.
[5] Included in investment in Aduro Biotech, Inc. on the Company's unaudited condensed consolidated balance sheets.
[6] Included in current liabilities on the Company's unaudited condensed consolidated balance sheets.
[7] Included in current liabilities on the Company's consolidated balance sheets.